CTRI/2021/10/037234
Not yet recruiting
未知
eurodevelopment outcomes at 2-3 years of age in very low birth weight infants following zinc supplementation
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: P84- Other problems with newbornHealth Condition 2: P84- Other problems with newborn
- Sponsor
- ot applicable
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •This follow up study includes Very low birth weight babies previously enrolled in a randomized control trial on Zinc supplementation for short term outcomes. These children will be followed up at 2\-3 years of age for neurodevelopmental outcomes. It was done by Dr Nikhil Tenneti( EC/06/18/1362\), DNB Fellow, Department of Neonatology at Sir Ganga Ram Hospital, New Delhi.
Exclusion Criteria
- •Refusal of Consent or lost to follow up
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
An observational study to see whether Neurodevelopmental outcome is affected at 18-24 months of age in Neonates with Mild HIE and borderline low Apgar without therapeutic hypothermiaCTRI/2020/01/022958one
Not yet recruiting
Not Applicable
eurodevelopmental outcomes by surgery in children operated for congenital heart disease in the neonatal periodKCT0009388Asan Medical Center40
Not yet recruiting
Not Applicable
A clinical trial to study the effects of multiple general anaesthesia exposures on long-term brain development in children with eye cancerCTRI/2022/03/041518All India Institute of Medical Sciences
Completed
Not Applicable
euro development of children born during COVID 19 in Belagavi cityCTRI/2023/10/058762Pratiksha Kalgutkar48
Recruiting
Not Applicable
eurodevelopment of the preterm infantBrain development in preterm infantsPrematurityNeurological - Other neurological disordersReproductive Health and Childbirth - Complications of newbornACTRN12615000591550Professor Paul Colditz237